Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S350000, C546S113000, C548S255000, C548S262200
Reexamination Certificate
active
07960406
ABSTRACT:
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketo fused azolopiperidine and azolopiperazine derivatives of Formula I:that possess unique antiviral activity are provided. These compounds are useful for the treatment of HIV and AIDS.
REFERENCES:
patent: 6469006 (2002-10-01), Blair et al.
patent: 6476034 (2002-11-01), Wang et al.
patent: 6573262 (2003-06-01), Wallace et al.
patent: 6825201 (2004-11-01), Wang et al.
patent: 6900206 (2005-05-01), Kadow et al.
patent: 6900323 (2005-05-01), Wang et al.
patent: 7348337 (2008-03-01), Wang et al.
patent: 7354924 (2008-04-01), Wang et al.
patent: 7396830 (2008-07-01), Wang et al.
patent: 7449476 (2008-11-01), Ruediger et al.
patent: 7504399 (2009-03-01), Wang et al.
patent: 2004/0063744 (2004-04-01), Wang et al.
patent: 2004/0063746 (2004-04-01), Regueiro-Ren et al.
patent: 2005/0209246 (2005-09-01), Ueda et al.
patent: 2005/0215543 (2005-09-01), Lin et al.
patent: 2005/0215544 (2005-09-01), Lin et al.
patent: 2005/0215545 (2005-09-01), Lin et al.
patent: 2005/0261296 (2005-11-01), Yeung et al.
patent: 2007/0155702 (2007-07-01), Chen et al.
patent: WO 00/76521 (2000-12-01), None
patent: WO 02/062423 (2002-08-01), None
patent: WO 02/085301 (2002-10-01), None
patent: WO 03/068221 (2003-08-01), None
patent: WO 03/103607 (2003-12-01), None
patent: WO 2004/043375 (2004-05-01), None
patent: WO 2005/016344 (2005-02-01), None
patent: WO 2005/121094 (2005-12-01), None
patent: WO 2007/103456 (2007-09-01), None
patent: WO2007/127635 (2007-11-01), None
Blair, W.S. et al., “HIV-1 entry—an expanding portal for drug discovery”, Drug Discovery Today, vol. 5, No. 5, pp. 183-194 (2000).
Dhar, T.G.M. et al., “Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 17, pp. 5019-5024 (2007).
Hotoda, H., “Small-molecule inhibitors of HIV-1 entry via chemokine receptors”, Drugs of the Future, vol. 24, No. 12, pp. 1355-1362 (1999).
Lu, R.-J. et al., “Design and Synthesis of Human Immunodeficiency Virus Entry Inhibitors: Sulfonamide as an Isotere for the α-Ketoamide Group”, Journal of Medicinal Chemistry, vol. 50, No. 26, pp. 6535-6544 (2007).
Meanwell, N.A. et al., “Inhibitors of the entry of HIV into host cells”, Current Opinion in Drug Discovery & Development, vol. 6, No. 4, pp. 451-461 (2003).
Sodroski, J.G., “HIV-1 Entry Inhibitors in the Side Pocket”, Cell, vol. 99, pp. 243-246 (1999).
Wang, J. et al., “Modification and structure-activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120”, Org, Biomol. Chem., vol. 3, pp. 1781-1786 (2005).
Carini David J.
Hamann Lawrence G.
Johnson Barry L.
Kadow John F.
Liu Zheng
Bristol--Myers Squibb Company
Levis John F.
Willis Douglas M
Wilson James O
LandOfFree
Diketo substituted pyrrolo[2,3-c] pyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diketo substituted pyrrolo[2,3-c] pyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diketo substituted pyrrolo[2,3-c] pyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2742829